Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOKETOCONAZOLE vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOKETOCONAZOLE vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOKETOCONAZOLE LEVOMILNACIPRAN
Total FAERS Reports 309 1,378
Deaths Reported 8 382
Death Rate 2.6% 27.7%
Hospitalizations 99 378
Average Patient Age 54.8 yrs 46.4 yrs
% Female Patients 86.3% 80.2%
FDA Approval Date Dec 30, 2021 Feb 4, 2019
Manufacturer Xeris Pharmaceuticals, Inc. Allergan, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription